)
AptarGroup (ATR) investor relations material
AptarGroup 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business Overview and Strategic Positioning
Leading provider in drug delivery, dosing, protection technologies, and consumer product dispensing, with $3.6B in 2024 revenue and a diversified portfolio across pharma, beauty, and closures.
Pharma is the largest segment, contributing 46% of revenue and 67% of adjusted EBITDA, with a focus on proprietary drug delivery systems and strong IP protection.
Beauty and Closures segments remain significant, with $1.2B and $700M in 2024 revenue, respectively, and recent revitalization and operational efficiency initiatives.
No single product or geography drives long-term growth, supporting a highly diversified model.
Sustainability is a key differentiator, recognized by major publications and integrated across all business lines.
Innovation, Technology, and Sustainability
Over 7,300 patents granted or pending, with R&D spend at ~3% of sales, primarily focused on pharma innovation.
Advanced dispensing and dosing solutions maximize user satisfaction and regulatory compliance, with cleanroom standards and high reliability (99.999%).
New product launches include recyclable nasal spray pumps, preservative-free ophthalmic systems, and digital health platforms.
Ongoing expansion of technology platforms, including digital and connected devices, AI-assisted quality control, and sustainable solutions.
The company leverages shared technology platforms and deep regulatory expertise to drive innovation and customer engagement.
Pharma Segment and Pipeline
Proprietary drug delivery systems account for 72% of pharma sales and are the main growth and profit engine, with strong positions in nasal, inhaler, eye care, dermal, and injectables.
The pharma pipeline has grown 54% in value and 46% in opportunities since 2019, with a 6+ year average project pipeline.
Systemic nasal drug delivery is a major innovation, expanding treatment options for neurological and cardiovascular diseases.
Sustained revenue from long-life-cycle products, with repeat business driving 90% of annual pharma revenue.
Recent collaborations, such as with Oura and Bausch + Lomb, enhance digital health and patient engagement capabilities.
Next AptarGroup earnings date
Next AptarGroup earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)